Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15251122
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Coupling tumor necrosis factor-alpha with alphaV integrin ligands improves its antineoplastic activity.

  2004cited by this paper
• Cytokines in cancer pathogenesis and cancer therapy

  2004cited by this paper
• Inhibition of Tumor Growth by Intramuscular Injection of cDNA Encoding Tumor Necrosis Factor α Coupled to NGR and RGD Tumor-Homing Peptides

  2004cited by this paper
• TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.

  2004cited by this paper
• TNF-alpha promotes progression of peritoneal metastasis as demonstrated using a green fluorescence protein (GFP)-tagged human gastric cancer cell line.

  2004cited by this paper
• The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients.

  2004cited by this paper
• Elevation of cytokine levels in cachectic patients with prostate carcinoma

  2003cited by this paper
• Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis.

  2003cited by this paper
• Increased Sensitivity of Injured and Adjacent Uninjured Rat Primary Sensory Neurons to Exogenous Tumor Necrosis Factor-α after Spinal Nerve Ligation

  2003cited by this paper
• Cytokines in the pathogenesis of cancer cachexia

  2003cited by this paper
• Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

  2003cited by this paper
• Infliximab for steroid‐refractory acute GVHD: A case series

  2003cited by this paper
• Ewing's sarcoma and peripheral primitive neuroectodermal tumor cells produce large quantities of bioactive tumor necrosis factor-alpha (TNF-alpha) after radiation exposure.

  2003cited by this paper
• Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

  2003cited by this paper
• Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.

  2003cited by this paper
• Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.

  2003cited by this paper
• Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy.

  2003cited by this paper
• Endometriosis and ovarian cancer: thoughts on shared pathophysiology.

  2003cited by this paper
• The safety of biologic agents in early rheumatoid arthritis.

  2003cited by this paper
• Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

  2003cited by this paper
• Role of tumor necrosis factor-alpha in graft-versus-host disease and graft-versus-leukemia responses.

  2003cited by this paper
• Selective targeted delivery of TNFalpha to tumor blood vessels.

  2003cited by this paper
• Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment.

  2003cited by this paper
• Current uses of isolated limb perfusion in the clinic and a model system for new strategies.

  2003cited by this paper
• Anti-TNF-alpha therapies: the next generation.

  2003cited by this paper
• Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders

  2003cited by this paper
• An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.

  2003cited by this paper
• The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.

  2002cited by this paper
• Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma

  2002cited by this paper
• Binding and functional comparisons of two types of tumor necrosis factor antagonists.

  2002cited by this paper
• Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action.

  2002cited by this paper
• The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans.

  2002cited by this paper
• Infliximab chimaeric anti‐tumour necrosis factor alpha monoclonal antibody treatment for patients with myelodysplastic syndromes

  2002cited by this paper
• Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration.

  2002cited by this paper
• TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

  2002cited by this paper
• Moving disease biology from the laboratory to the clinic.

  2002cited by this paper
• Tumor necrosis factor or tumor promoting factor?

  2002cited by this paper
• Cachexia in cancer patients

  2002cited by this paper
• Improving chemotherapeutic drug penetration in tumors by vascular targeting and barrier alteration.

  2002cited by this paper
• Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept.

  2002cited by this paper
• The role of cytokines in cancer‐related fatigue

  2001cited by this paper
• Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor alpha receptor IgG1-Fc fusion complex therapy.

  2001cited by this paper
• Serum levels of tumor necrosis factor-alpha and nutritional status in pancreatic cancer patients.

  2001cited by this paper
• Tumor Necrosis Factor-α Induces Differentiation of and Bone Resorption by Osteoclasts*

  2000cited by this paper
• Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites

  2000cited by this paper
• Serum tumour necrosis factor‐α levels in cancer patients are discontinuous and correlate with weight loss

  2000cited by this paper
• Clinical applications of TNF-alpha in cancer.

  1998cited by this paper
• Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma.

  1998cited by this paper
• Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma.

  1998cited by this paper
• Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera.

  1996cited by this paper
• Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer.

  1995cited by this paper
• Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability

  1993cited by this paper

• Effect of bone marrow stem cell conditioned medium on amiodarone-induced submandibular salivary gland and kidney damage in male albino rats

  2026cites this paper
• TNFα activation of the PLEKHA5-FCRLA axis disturbs lipid metabolism, leading to the progression of cutaneous malignant melanoma

  2025cites this paper
• Piribedil and thymol mitigate vancomycin-evoked nephrotoxicity in rats through modulation of Keap-1/Nrf2/HO-1 and NF-κB/Bax/caspase 3 signalings

  2025cites this paper
• Short-term high-dose gemcitabine induces PERK-mediated immunogenic cell death and potentiates antitumor immunity in bladder cancer.

  2025cites this paper
• Downregulation of TNFAIP3 Associated With Poor Prognosis and Immune Response in Breast Cancer

  2025cites this paper
• Structural and anti-colorectal cancer modulation of tumor necrosis factor-alpha (TNF-α) protein by gaillardin: Experimental and theoretical analyses.

  2025cites this paper
• Risk of hematologic malignancies in psoriasis and rheumatoid arthritis patients using long term TNF-α inhibitors: a retrospective nationwide study

  2025cites this paper
• Double-faced CX3CL1 enhances lymphangiogenesis-dependent metastasis in an aggressive subclone of oral squamous cell carcinoma

  2024cites this paper
• Nanosphere pharmacodynamics improves safety of immunostimulatory cytokine therapy

  2024cites this paper
• Serum IL-17 and TNFα as prognostic biomarkers in systemic sclerosis patients: a prospective study

  2023cites this paper
• Synthesis and anticancer properties of celastrol derivatives involved in the inhibition of VEGF

  2023cites this paper
• Nanoparticle-based drug delivery systems in cancer: A focus on inflammatory pathways.

  2022cites this paper
• Lactulose Modulates the Structure of Gut Microbiota and Alleviates Colitis-Associated Tumorigenesis

  2022cites this paper
• Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells

  2021cites this paper
• Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases

  2020cites this paper
• Molecular mechanism of gossypol mediating CCL2 and IL-8 attenuation in triple-negative breast cancer cells

  2020cites this paper
• Evaluation of the Cardiac Protection Conferred by Proanthocyanidins in Grape Seeds against Development of Ehrlich Solid Tumors in Mice

  2020cites this paper
• Elevated Levels of TNF-α and Decreased Levels of CD68-Positive Macrophages in Primary Tumor Tissues Are Unfavorable for the Survival of Patients With Nasopharyngeal Carcinoma

  2019cites this paper
• Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer

  2019cites this paper
• Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates.

  2019cites this paper
• Size-Dependent Effect of Silver Nanoparticles on the Tumor Necrosis Factor α-Induced DNA Damage Response

  2019cites this paper
• Tumor Necrosis Factor-α Produced by Osteoclasts Might Induce Intractable Pain in a Rat Spinal Metastasis Model of Breast Cancer

  2019cites this paper
• Cytokine networks and their association with Helicobacter pylori infection in gastric carcinoma

  2018cites this paper
• TNF-R2 in tumor microenvironment as prognostic factor in epithelial ovarian cancer

  2018cites this paper
• Spine Surgery and Related Research

  2018cites this paper
• A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice

  2018cites this paper
• The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells

  2018cites this paper
• TNFα induces Ca2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells

  2018cites this paper
• Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms

  2017cites this paper
• TNF Neutralization Results in the Delay of Transplantable Tumor Growth and Reduced MDSC Accumulation

  2016cites this paper
• Tumor Necrosis Factor-α T-857C (rs1799724) Polymorphism and Risk of Cancers: A Meta-Analysis

  2016cites this paper
• Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

  2016cites this paper
• STUDY OF THE ANTICANCER POTENTIAL OF CELERY SEED OIL AGAINST CHEMICALLY INDUCED HEPATOCELLULAR CARCINOMA IN RATS: A MECHANISTIC APPROACH.

  2016cites this paper
• Tumor Necrosis Factor-α, a Regulator and Therapeutic Agent on Breast Cancer.

  2016cites this paper
• The tumor necrosis factor-α-238 polymorphism and digestive system cancer risk: a meta-analysis

  2016cites this paper
• TNF-α evaluation in tonsil cancer.

  2015cites this paper
• Blockade of TNF-α signaling benefits cancer therapy by suppressing effector regulatory T cell expansion

  2015cites this paper
• –308 G/A TNF-α gene polymorphism influences the course of basal cell carcinoma in a Polish population

  2015cites this paper
• Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer

  2015cites this paper
• Pristimerin Inhibits Prostate Cancer Bone Metastasis by Targeting PC-3 Stem Cell Characteristics and VEGF-Induced Vasculogenesis of BM-EPCs

  2015cites this paper
• A Simple and Rapid Method for Expression and Purification of Functional TNF-α Using GST Fusion System.

  2015cites this paper
• Effect of resistance training on natural killer cell activity in women treated for breast cancer treatment : findings from a randomised controlled trial

  2014cites this paper
• RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer

  2014cites this paper
• Population differences concerning TNF-α gene polymorphisms in gastric carcinogenesis based on meta-analysis

  2014cites this paper
• Chronic Inflammation and Cytokines in the Tumor Microenvironment

  2014cites this paper
• Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms

  2014cites this paper
• Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML

  2014cites this paper
• Distinct expression and localization of TNF system in ovarian carcinoma tissues: possible involvement of TNF-α in morphological changes of ovarian cancerous cells.

  2014cites this paper
• Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk

  2014cites this paper
• The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis

  2014cites this paper
• Genomic aspects of NAFLD pathogenesis.

  2013cites this paper
• Immunomodulatory Effect of Stichopus japonicus Acid Mucopolysaccharide on Experimental Hepatocellular Carcinoma in Rats

  2013cites this paper
• Thalidomide distinctly affected TNF-α, IL-6 and MMP secretion by an ovarian cancer cell line (SKOV-3) and primary ovarian cancer cells.

  2013cites this paper
• The immune system in the pathogenesis of ovarian cancer.

  2013cites this paper
• Significance of Tumor Necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer

  2012cites this paper
• Cancer-related inflammation: common themes and therapeutic opportunities.

  2012cites this paper
• Systemic inflammation and prediction of chemotherapy outcomes in patients receiving docetaxel for advanced cancer

  2012cites this paper
• Observational studies on the risk of cancer associated with tumor necrosis factor inhibitors in rheumatoid arthritis: a review of their methodologies and results.

  2012cites this paper
• Resistance to TRAIL and how to surmount it

  2012cites this paper
• Luteolin Inhibits Human Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis

  2012cites this paper
• In vitro blockade of adhesion of breast cancer cells to endothelial cells using anti-inflammatory drugs.

  2012cites this paper
• Novel Apoptotic Regulators in Carcinogenesis

  2012cites this paper
• The lymphotoxin-α 252A>G polymorphism and breast cancer: a meta-analysis.

  2012cites this paper
• DAPk1 inhibits NF-κB activation through TNF-α and INF-γ-induced apoptosis.

  2012cites this paper
• Genetic Variation in IL‐6 and TNF‐α Genes with Risk of Breast Cancer in a Saudi Population‐based Case–Control Study

  2012cites this paper
• HIF-1α Acts Downstream of TNF-α to Inhibit Vasodilator-Stimulated Phosphoprotein Expression and Modulates the Adhesion and Proliferation of Breast Cancer Cells

  2012cites this paper
• Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.

  2012cites this paper
• TNF-alpha polymorphisms and breast cancer

  2011cites this paper
• Breast cancer cell-derived cytokines, macrophages and cell adhesion: implications for metastasis.

  2011cites this paper
• Polymorphisms of Tumor Necrosis Factor-Alpha and Hepatocellular Carcinoma Risk: A HuGE Systematic Review and Meta-Analysis

  2011cites this paper
• Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.

  2011cites this paper
• TNF alpha antagonist therapy and safety monitoring.

  2011cites this paper
• Tumor Necrosis Factor Alpha 308 G/A Polymorphism and Hepatocellular Carcinoma Risk in a Chinese Population

  2011cites this paper
• Tumor necrosis factor alpha 308 G/A polymorphism and Guillain-Barré syndrome risk

  2011cites this paper
• Interleukin-22 Suppresses the Growth of A498 Renal Cell Carcinoma Cells via Regulation of STAT1 Pathway

  2011cites this paper
• The TNF-Alpha-238 Polymorphism and Cancer Risk: A Meta-Analysis

  2011cites this paper
• Production of bioactive, SUMO-modified, and native-like TNF-α of the rhesus monkey, Macaca mulatta, in Escherichia coli

  2011cites this paper
• The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis

  2011cites this paper
• FAT10 mediates the effect of TNF-α in inducing chromosomal instability

  2011cites this paper
• Elevated expression of tumor necrosis factor‐α signaling molecules in colonic tumors of Zucker obese (fa/fa) rats

  2010cites this paper
• Association between -238 but not -308 polymorphism of Tumor necrosis factor alpha (TNF-alpha)v and unexplained recurrent spontaneous abortion (URSA) in Chinese population

  2010cites this paper
• A study of TNF‐alpha‐238 and ‐308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China

  2010cites this paper
• Netrin-1, a missing link between chronic inflammation and tumor progression

  2010cites this paper
• TNF-α and its inhibitors in cancer

  2010cites this paper
• Soluble Angiogenesis Factors in Sera of Egyptian Patients with Hepatitis C Virus Infection: Correlation with Disease Severity

  2010cites this paper
• The dual role of tumor necrosis factor (TNF) in cancer biology.

  2010cites this paper
• Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer.

  2010cites this paper
• Cancer and Inflammation: Implications for Pharmacology and Therapeutics

  2010cites this paper
• Significance of Serum Tumor Necrosis Factor-Alpha and its Combination with Her-2 Codon 655 Polymorphism in the Diagnosis and Prognosis of Breast Cancer

  2010cites this paper
• Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis

  2010cites this paper
• Chromogranin A and the Tumor Microenvironment

  2010cites this paper
• Targeting death receptors to fight cancer: from biological rational to clinical implementation.

  2010cites this paper
• Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer.

  2009cites this paper
• TNF-alpha downregulates E-cadherin and sensitizes response to γ-irradiation in Caco-2 cells.

  2009cites this paper
• G-308A TNF-alpha polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.

  2009cites this paper
• Tumour necrosis factor and cancer

  2009cites this paper
• The Major Histocompatibility Complex Conserved Extended Haplotype 8.1 in AIDS-Related Non-Hodgkin Lymphoma

  2009cites this paper
• Perispinal etanercept for neuroinflammatory disorders.

  2009cites this paper
• Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma

  2009cites this paper
• Gene expression of the invasive phenotype of TNF-alpha-treated MCF-7 cells.

  2009cites this paper